{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper links ␣-synuclein (␣S) to Parkinson disease through its deposition in an amyloid fibril form within Lewy Body deposits, and by the existence of three ␣S point mutations that lead to early onset autosomal dominant Parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for the A30P variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses pulsed dipolar ESR measurements to assess the effects of PD-linked mutations on the detergent-and membrane-bound conformations of ␣S.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (ESR spectroscopy) effectively models the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper describes the use of basic controls and replicates, including wild-type and mutant proteins, and mentions the use of multiple replicates.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were included, meeting the criteria for proceeding to Sub-step 3c.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study includes known pathogenic variants (A30P, E46K, A53T) as controls.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants were used as controls, meeting the criteria for proceeding to Step 4.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper does not provide statistical analyses sufficient to estimate or calculate OddsPath for the functional data.",
          "judgment": "No",
          "reasoning": "Statistical analyses for OddsPath calculation are not provided, leading to Sub-step 4b.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study uses three known pathogenic variants as controls.",
          "judgment": "Yes",
          "reasoning": "With fewer than 11 total variant controls, the functional evidence strength is limited to supporting.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A30P variant retains the ability to adopt both broken and extended helix conformations, but with increased local disorder, supporting a pathogenic role with supporting strength due to the use of known pathogenic controls but insufficient statistical analysis for higher strength."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper links ␣-synuclein (␣S) to Parkinson disease through its deposition in an amyloid fibril form within Lewy Body deposits, and by the existence of three ␣S point mutations that lead to early onset autosomal dominant Parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for the E46K variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses pulsed dipolar ESR measurements to assess the effects of PD-linked mutations on the detergent-and membrane-bound conformations of ␣S.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (ESR spectroscopy) effectively models the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper describes the use of basic controls and replicates, including wild-type and mutant proteins, and mentions the use of multiple replicates.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were included, meeting the criteria for proceeding to Sub-step 3c.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study includes known pathogenic variants (A30P, E46K, A53T) as controls.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants were used as controls, meeting the criteria for proceeding to Step 4.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper does not provide statistical analyses sufficient to estimate or calculate OddsPath for the functional data.",
          "judgment": "No",
          "reasoning": "Statistical analyses for OddsPath calculation are not provided, leading to Sub-step 4b.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study uses three known pathogenic variants as controls.",
          "judgment": "Yes",
          "reasoning": "With fewer than 11 total variant controls, the functional evidence strength is limited to supporting.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The E46K variant retains the ability to adopt both broken and extended helix conformations, similar to wild-type, supporting a pathogenic role with supporting strength due to the use of known pathogenic controls but insufficient statistical analysis for higher strength."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper links ␣-synuclein (␣S) to Parkinson disease through its deposition in an amyloid fibril form within Lewy Body deposits, and by the existence of three ␣S point mutations that lead to early onset autosomal dominant Parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for the A53T variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses pulsed dipolar ESR measurements to assess the effects of PD-linked mutations on the detergent-and membrane-bound conformations of ␣S.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (ESR spectroscopy) effectively models the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper describes the use of basic controls and replicates, including wild-type and mutant proteins, and mentions the use of multiple replicates.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were included, meeting the criteria for proceeding to Sub-step 3c.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study includes known pathogenic variants (A30P, E46K, A53T) as controls.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants were used as controls, meeting the criteria for proceeding to Step 4.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper does not provide statistical analyses sufficient to estimate or calculate OddsPath for the functional data.",
          "judgment": "No",
          "reasoning": "Statistical analyses for OddsPath calculation are not provided, leading to Sub-step 4b.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study uses three known pathogenic variants as controls.",
          "judgment": "Yes",
          "reasoning": "With fewer than 11 total variant controls, the functional evidence strength is limited to supporting.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A53T variant retains the ability to adopt both broken and extended helix conformations, similar to wild-type, supporting a pathogenic role with supporting strength due to the use of known pathogenic controls but insufficient statistical analysis for higher strength."
    }
  ]
}